Functional and structural improvement of knee arthropathy in CINCA syndrome under treatment with recombinant human interleukin-1 receptor antagonist (anakinra).

Donato Rigante, Adele Compagnone, Achille Stabile, S Gaspari

Research output: Contribution to journalArticle

Abstract

A child with CINCA syndrome has received a biologic treatment with anakinra, showing a paramount response at both clinical and laboratory level. In particular, the response of the skeletal signs of this disease is widely dicussed.
Original languageEnglish
Pages (from-to)283-283
Number of pages1
JournalBONE
Volume2007
Publication statusPublished - 2007

Keywords

  • Anakinra

Fingerprint

Dive into the research topics of 'Functional and structural improvement of knee arthropathy in CINCA syndrome under treatment with recombinant human interleukin-1 receptor antagonist (anakinra).'. Together they form a unique fingerprint.

Cite this